Skip to main content
HighlightsHighlights Archive

Media Monitoring: 12th – 18th November

By November 18, 2022No Comments

Detecting the undetected: measuring levels of three proteins in the blood can aid detection of undiagnosed prediabetes

  • New research has identified a three-protein signature in the blood that can improve detection of impaired glucose tolerance, a form of prediabetes
  • Their results also indicate that fasting before the blood sample is taken does not significantly change the reliability of the three-protein signature for identifying people with impaired glucose tolerance, which would greatly increase the application of the test in clinical practice
  • The authors used a proteomic assay, a means of using technologies to identify and quantify proteins present in a cell, to measure blood levels of nearly 5,000 proteins in samples from more than 11,000 participants in the Fenland Study, each of whom underwent an oral glucose tolerance test


Children to be screened for diabetes risk in UK early detection trial

  • A trial is being launched to screen for type 1 diabetes to diagnose the condition earlier and avoid complications
  • 20,000 children aged between three and 13 are being invited to take part in the Early Surveillance for Autoimmune Diabetes study and will begin on Monday
  • More than a quarter of children in the UK are not diagnosed with type 1 diabetes until they are in diabetic ketoacidosis (DKA) – a major problem which requires urgent attention


Atherosclerosis can be cured if it is spotted in early in life

  • Researchers have discovered that that elevated lipids and dyslipidaemia in early life may make cases of atherosclerosis worse in later life
  • They also found that stimulated lipid treatment in adolescence could halt the progression of the disease
  • The findings show that a screening programme for elevated lipids and dyslipidaemia would be highly effective if employed


NHS Providers picks next chief executive

  • Julian Hartley, CEO of The Leeds Teaching Hospitals NHS Trust, has been selected as the NHS Providers new CEO
  • He will replace Saffron Cordery from the 1st of February 2023


Benign breast disease increases the risk of breast cancer

  • Spanish researchers have found that women with benign breast cancer are still twice as likely to be diagnosed with breast cancer
  • This risk persisted for 20 years following diagnosis, prompting researchers to suggest increased screening for those with breast disease
  • Data showed that around 25 out of every 1,000 women with benign breast disease were subsequently diagnosed with breast cancer



Natalie Creaney